> We tried the silly will power way, that did not work.
They still work for plenty of people, just not you. They can work for more if we enable healthy diets and lifestyles as a society.
And no, that's not a "gold star" to the people who were able to literally have their "machine" work as designed. It's rather a gold star for you to not acknowledge if you needed artificial assistance to exist.
> Is this why GLP-1s are so effective at scale... We tried GLP-1s, and they clearly work because industries are shifting because of it.
None of the articles you cited in your earlier comment address "scale" at all, nor provide evidence of "shifting industries." Two of them address changes in the spending patterns of high-income consumers who are already using the drug (unrelated to the proportion of the total population using the drug), and the third is a blog post by a doctor literally selling GLP-1s as a miracle drug ("It's getting to the point of wondering what GLP-1 agonists aren't good for"-- yikes).
Your most recent KFF link (which it looks like you removed) claims 12% of adults have taken GLP-1 drugs (going off of a single poll taken by a health-tracking organization-- probably biased towards people actively working on their health). If that number was true, it would be alarming that over 10% of humans needed an artificial fix for a problem created by the food industry and socially sanctioned sedentary lifestyles, not something to parade around like you've actually fixed the underlying problem.
They still work for plenty of people, just not you. They can work for more if we enable healthy diets and lifestyles as a society.
And no, that's not a "gold star" to the people who were able to literally have their "machine" work as designed. It's rather a gold star for you to not acknowledge if you needed artificial assistance to exist.
> Is this why GLP-1s are so effective at scale... We tried GLP-1s, and they clearly work because industries are shifting because of it.
None of the articles you cited in your earlier comment address "scale" at all, nor provide evidence of "shifting industries." Two of them address changes in the spending patterns of high-income consumers who are already using the drug (unrelated to the proportion of the total population using the drug), and the third is a blog post by a doctor literally selling GLP-1s as a miracle drug ("It's getting to the point of wondering what GLP-1 agonists aren't good for"-- yikes).
Your most recent KFF link (which it looks like you removed) claims 12% of adults have taken GLP-1 drugs (going off of a single poll taken by a health-tracking organization-- probably biased towards people actively working on their health). If that number was true, it would be alarming that over 10% of humans needed an artificial fix for a problem created by the food industry and socially sanctioned sedentary lifestyles, not something to parade around like you've actually fixed the underlying problem.